BFS
AMPH icon

Bare Financial Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bare Financial Services’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464 Sell
23
-23
-50% -$464 ﹤0.01% 1727
2026
Q1 		$901 Buy
+46
New +$1.13K ﹤0.01% 1296
2025
Q3 		– Sell
-19
Closed -$436 – 1395
2025
Q2 		$436 Buy
+19
New +$471 ﹤0.01% 1168

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bare Financial Services's AMPH Position: Q2 2026 in Review

Bare Financial Services reduced its Amphastar Pharmaceuticals (AMPH) stake by 50% in Q2 2026, selling an estimated $464 and leaving 23 shares worth $464. The position accounts for ﹤0.01% of the portfolio, ranked #1727.

Bare Financial Services first reported a position in AMPH in Q2 2025 and has held it in 3 quarters since. The position peaked at $901 in Q1 2026. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Bare Financial Services held 23 shares of Amphastar Pharmaceuticals worth $464 as of Q2 2026.
  • Bare Financial Services sold 23 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $464.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1727 holding.
  • Bare Financial Services first reported a position in Amphastar Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • Bare Financial Services's Amphastar Pharmaceuticals position peaked at $901 in Q1 2026.
  • 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.